Aurobindo FDA Tuesday, January 27, 2009 0.00 Neutral

FDA Approves LAMOTRIGINE — Aurobindo Pharma Limited

Aurobindo Pharma Limited secured final FDA approval for its generic Lamotrigine oral tablets, a development anticipated to enhance the company's market share in the anticonvulsant segment and facilitate additional revenue growth.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day